Erratum: Antibodies from multiple sclerosis patients preferentially recognize hyperglucosylated adhesin of non-typeable Haemophilus influenzae (Scientific Reports (2016) 6 (39430) DOI: 10.1038/srep39430);Antibodies from multiple sclerosis patients preferentially recognize hyperglucosylated adhesin of non-typeable Haemophilus influenzae

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Walvoort, Marthe T C ^a   Testa, Chiara ^b   Eilam, Raya ^c   Aharoni, Rina ^c   Nuti, Francesca ^b   Rossi, Giada ^b   Real Fernandez, Feliciana ^b   Lanzillo, Roberta ^d   Brescia Morra, Vincenzo ^d   Lolli, Francesco ^e   Rovero, Paolo ^b   Imperiali, Barbara ^a   Papini, Anna Maria ^b,f  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF FLORENCE   (Italy)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e UNIVERSITY OF FLORENCE   (Italy)

^f Université Paris Seine   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; ANTIBODY; ASPARAGINE; BACTERIAL ANTIGEN; GLYCOCONJUGATE; GLYCOPEPTIDE; OUTER MEMBRANE PROTEIN;

ADULT; AGED; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; YOUNG ADULT;

ADHESINS, BACTERIAL; ADULT; AGED; ANTIBODIES; ANTIGENS, BACTERIAL; ASPARAGINE; BACTERIAL OUTER MEMBRANE PROTEINS; FEMALE; GLYCOCONJUGATES; GLYCOPEPTIDES; HAEMOPHILUS INFLUENZAE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; YOUNG ADULT;

EID: 85007232679     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep44969     Document Type: Erratum

References (52)

1. McFarland, H. F. & Martin, R. Multiple sclerosis: a complicated picture of autoimmunity. Nat Immunol 8, 913-9 (2007).
2. Noseworthy, J. H., Lucchinetti, C., Rodriguez, M. & Weinshenker, B. G. Multiple sclerosis. N Engl J Med 343, 938-52 (2000).
3. Ascherio, A. & Munger, K. L. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 61, 288-99 (2007), Part II: Noninfectious factors. Ann Neurol 61, 504-13 (2007).
4. Aharoni, R. New findings and old controversies in the research of multiple sclerosis and its model experimental autoimmune encephalomyelitis. Expert Rev Clin Immunol 9, 423-40 (2013).
5. Sherbet, G. Bacterial Infections and the Pathogenesis of Autoimmune Conditions. Br J Med Pract 2, 6-13 (2009).
6. Ercolini, A. M. & Miller, S. D. The role of infections in autoimmune disease. Clin Exp Immunol 155, 1-15 (2009).
7. Berger, T. & Reindl, M. Antibody biomarkers in CNS demyelinating diseases - a long and winding road. Eur J Neurol 22, 1162-8 (2015).
8. Levin, M. C. et al. Autoantibodies to Non-myelin Antigens as Contributors to the Pathogenesis of Multiple Sclerosis. J Clin Cell Immunol 4 (2013).
9. Fraussen, J., Claes, N., de Bock, L. & Somers, V. Targets of the humoral autoimmune response in multiple sclerosis. Autoimmun Rev 13, 1126-37 (2014).
10. Pröbstel, A. K. et al. Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology 77, 580-8 (2011).
11. Mayer, M. C. & Meinl, E. Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more. Ther Adv Neurol Disord 5, 147-59 (2012).
12. Reindl, M., Di Pauli, F., Rostásy, K. & Berger, T. The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol 9, 455-61 (2013).
13. Mazzucco, S. et al. A synthetic glycopeptide of human myelin oligodendrocyte glycoprotein to detect antibody responses in multiple sclerosis and other neurological diseases. Bioorg Med Chem Lett 9, 167-72 (1999).
14. Lolli, F. et al. An N-glucosylated peptide detecting disease-specific autoantibodies, biomarkers of multiple sclerosis. Proc Natl Acad Sci USA 102, 10273-8 (2005).
15. Lolli, F. et al. The glycopeptide CSF114(Glc) detects serum antibodies in multiple sclerosis. J Neuroimmunol 167, 131-7 (2005).
16. Real-Fernández, F. et al. Glycopeptide-based antibody detection in multiple sclerosis by surface plasmon resonance. Sensors (Basel) 12, 5596-607 (2012).
17. Carotenuto, A. et al. Designed glycopeptides with different beta-turn types as synthetic probes for the detection of autoantibodies as biomarkers of multiple sclerosis. J Med Chem 51, 5304-9 (2008).
18. Schreiner, R., Schnabel, E. & Wieland, F. Novel N-glycosylation in eukaryotes: laminin contains the linkage unit betaglucosylasparagine. J Cell Biol 124, 1071-81 (1994).
19. Calo, D., Kaminski, L. & Eichler, J. Protein glycosylation in Archaea: sweet and extreme. Glycobiology 20, 1065-76 (2010).
20. de Seze, J. et al. Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis. Mult Scler 9, 521-5 (2003)
21. Jarius, S. et al. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 131, 3072-80 (2008)
22. Tan, F. Y., Tang, C. M. & Exley, R. M. Sugar coating: bacterial protein glycosylation and host-microbe interactions. Trends Biochem Sci 40, 342-50 (2015).
23. Grass, S. et al. The Haemophilus influenzae HMW1 adhesin is glycosylated in a process that requires HMW1C and phosphoglucomutase, an enzyme involved in lipooligosaccharide biosynthesis. Mol Microbiol 48, 737-51 (2003).
24. Gross, J. et al. The Haemophilus influenzae HMW1 adhesin is a glycoprotein with an unusual N-linked carbohydrate modification. J Biol Chem 283, 26010-5 (2008).
25. Kawai, F. et al. Structural insights into the glycosyltransferase activity of the Actinobacillus pleuropneumoniae HMW1C-like protein. J Biol Chem 286, 38546-57 (2011).
26. Naegeli, A. et al. Substrate specificity of cytoplasmic N-glycosyltransferase. J Biol Chem 289, 24521-32 (2014).
27. Schwarz, F., Fan, Y. Y., Schubert, M. & Aebi, M. Cytoplasmic N-glycosyltransferase of Actinobacillus pleuropneumoniae is an inverting enzyme and recognizes the NX(S/T) consensus sequence. J Biol Chem 286, 35267-74 (2011).
28. Choi, K. J., Grass, S., Paek, S. St, Geme, J. W. & Yeo, H. J. The Actinobacillus pleuropneumoniae HMW1C-like glycosyltransferase mediates N-linked glycosylation of the Haemophilus influenzae HMW1 adhesin. PLoS One 5, e15888 (2010).
29. Yang, J. et al. The I-TASSER Suite: protein structure and function prediction. Nat Methods 12, 7-8 (2015).
30. Zhang, Y. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 9, 40 (2008).
31. Grass, S., Lichti, C. F., Townsend, R. R., Gross, J. & St Geme, J. W. The Haemophilus influenzae HMW1C protein is a glycosyltransferase that transfers hexose residues to asparagine sites in the HMW1 adhesin. PLoS Pathog 6, e1000919 (2010).
32. Gawthorne, J. A. et al. Selection against glycosylation sites in potential target proteins of the general HMWC N-glycosyltransferase in Haemophilus influenzae. Biochem Biophys Res Commun 445, 633-8 (2014).
33. Naegeli, A. et al. Molecular analysis of an alternative N-glycosylation machinery by functional transfer from Actinobacillus pleuropneumoniae to Escherichia coli. J Biol Chem 289, 2170-9 (2014).
34. Mao, Z., Shin, H. D. & Chen, R. R. Engineering the E. coli UDP-glucose synthesis pathway for oligosaccharide synthesis. Biotechnol Prog 22, 369-74 (2006).
35. Rath, S., Stanley, C. M. & Steward, M. W. An inhibition enzyme immunoassay for estimating relative antibody affinity and affinity heterogeneity. J Immunol Methods 106, 245-9 (1988).
36. Aharoni, R. et al. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate. J Autoimmun 37, 228-41 (2011).
37. Hitchen, P. G. & Dell, A. Bacterial glycoproteomics. Microbiology 152, 1575-80 (2006).
38. Hitchen, P. G. et al. Glycoproteomics: a powerful tool for characterizing the diverse glycoforms of bacterial pilins and flagellins. Biochem Soc Trans 38, 1307-13 (2010).
39. Balonova, L., Hernychova, L. & Bilkova, Z. Bioanalytical tools for the discovery of eukaryotic glycoproteins applied to the analysis of bacterial glycoproteins. Expert Rev Proteomics 6, 75-85 (2009).
40. Balonova, L. et al. Multimethodological approach to identification of glycoproteins from the proteome of Francisella tularensis, an intracellular microorganism. J Proteome Res 9, 1995-2005 (2010).
41. Schmidt, M. A., Riley, L. W. & Benz, I. Sweet new world: glycoproteins in bacterial pathogens. Trends Microbiol 11, 554-61 (2003).
42. Schäffer, C. et al. Purification and structure elucidation of the N-acetylbacillosamine-containing polysaccharide from Bacillus licheniformis ATCC 9945. Eur J Biochem 268, 857-64 (2001).
43. Tissot, B. et al. Glycoproteomics: past, present and future. FEBS Lett 583, 1728-35 (2009).
44. McNally, D. J. et al. Identification of labile UDP-ketosugars in Helicobacter pylori, Campylobacter jejuni and Pseudomonas aeruginosa: key metabolites used to make glycan virulence factors. Chembiochem 7, 1865-8 (2006).
45. Comstock, L. E. & Kasper, D. L. Bacterial glycans: key mediators of diverse host immune responses. Cell 126, 847-50 (2006).
46. Young, K. T., Davis, L. M. & Dirita, V. J. Campylobacter jejuni: molecular biology and pathogenesis. Nat Rev Microbiol 5, 665-79 (2007).
47. Hughes, R. A. & Cornblath, D. R. Guillain-Barré syndrome. Lancet 366, 1653-66 (2005).
48. Yuki, N. et al. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. Proc Natl Acad Sci USA 101, 11404-9 (2004).
49. Sakiyama, Y. et al. New type of encephalomyelitis responsive to trimethoprim/sulfamethoxazole treatment in Japan. Neurol Neuroimmunol Neuroinflamm 13, e143 (2015).
50. Amor, S., Puentes, F., Baker, D. & van der Valk, P. Inflammation in neurodegenerative diseases. Immunology 129, 154-69 (2010).
51. Itzhaki, R. F. et al. Microbes and Alzheimer's Diseases. J Alzheimers Dis 51, 979-84 (2016).
52. Polman, C. H. et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69, 292-302 (2011).